RCTS Clinical - Testing

11/03/2025

STUDY ENROLLING!!! See Details and call us at (972) 871-7578/Option 1!

RCTS, Inc.

09/10/2025

Check out this new study at ALS Irving and call us at (972) 871-7578/Option 1 to get started!
Panel 4489
100 Male & Females Ages 18-60
Testing a Facial Product
7 visits over 12 weeks
Requirements:
Males and Females
Must have at least 1 persistent dark spot that's been visible for 3+ months, at least 3mm wide
Must be showing signs of aging.
Study pays upon completion: $450
Study Start Dates: 9/15, 9/17, 10/13, 10/16, 11/12, 11/17, 11/25/25

08/26/2025

GET ALS-IRVING STUDIES SENT TO YOUR EMAIL!

Use the QR code below to sign up for our email list. See what's enrolling, get links to our applications, send us your questions - all from your inbox. We look forward to seeing you soon!

08/05/2025

ALS-Irving (formerly RCTS), a clinical testing facility for topical cosmetic and personal care products in central Dallas-Fort Worth is searching for adult volunteers with eczema to participate in a clinical trial testing an eczema treatment product. See details below!
___________________________________________________________________________

Study Details
4 Visits in office
Up to $325.00 for all complete visits
This is a research study related to the efficacy and overall safety of a topical eczema treatment. The sponsor is interested in learning more about the product.
Qualifications
• Males and Females
• Age 18 to 70
• Have active eczema on the head/neck, torso, arms, or legs
__________________________________________________________________________

To inquire about participation in this or other studies, press the Call Now button on this ad. You can also visit these links:

ALS-Irving Studies Page:

https://www.alsglobal.com/en/Clinical-Studies/Irving-TX?lang=en&gender=&agegroup=&race=&type=&sort=&sortDir=

Apply to Participate (Application for ages 18+):

https://www.alsglobal.com/en/Clinical-Studies/Irving-TX/Eligibility-Adults

RCTS, Inc.

07/25/2025

This study is CURRENTLY ENROLLING! If you or someone you know has eczema, call us at (972) 871-7578/Option 1 to get more information or get started!

Check out this new ALS-Irving study and call us at (972) 871-7578/Option 1 to get started!

Study Details
4 Visits in office
Up to $325.00 for all complete visits
This is a research study related to the efficacy and overall safety of a topical eczema treatment. The sponsor is interested in learning more about the product.

Qualifications
• Males and Females
• Age 18 to 70
• Have active eczema on the head/neck, torso, arms, or legs

07/14/2025

Check out this new ALS-Irving study and call us at (972) 871-7578/Option 1 to get started!

Study Details
4 Visits in office
Up to $325.00 for all complete visits
This is a research study related to the efficacy and overall safety of a topical eczema treatment. The sponsor is interested in learning more about the product.

Qualifications
• Males and Females
• Age 18 to 70
• Have active eczema on the head/neck, torso, arms, or legs

02/24/2025

LOOKING FOR CONTACT WEARERS IN DFW!

Do you or someone you know wear contact lenses? Make some extra money by signing up for studies at RCTS or referring people you know! **$50 per qualified referral.** Send your friends the link!

"I wear contacts, but just for fashion or to change my look." That's okay! Whether you wear them to correct eyesight or just to have some fun, you still qualify. Apply today!

New panelists fill out our application here:
https://www.alsglobal.com/en/Clinical-Studies/Irving-TX/Eligibility-Adults

02/19/2025

Good morning everyone!

We are OPEN today, February 19, 2025 for all scheduled studies. If you are scheduled to come in today, you should come in at your given appointment time.

Please message us here if you have any questions! We will send updates if conditions require.

12/24/2024

We want to wish everyone a happy and joyful holiday season!

RCTS, an ALS Global Company, will be closed for the holidays starting Tuesday December 24, 2024. We will reopen with normal business hours on Thursday, January 2, 2025.

We look forward to seeing you on studies in the New Year!